Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Third Harmonic Bio, Inc. ( (THRD) ) has provided an update.
On February 11, 2025, Third Harmonic Bio, Inc. announced a restructuring plan aimed at reducing operating costs and aligning its workforce with its strategic research and development goals. This plan involves reducing the workforce by approximately 27 employees, or 50%, with severance benefits contingent upon acceptance of a severance agreement, and is expected to incur around $2.3 million in severance and exit costs. After these restructuring costs and other expenses, the company expects to have cash and equivalents of $262 million to $267 million by June 30, 2025.
More about Third Harmonic Bio, Inc.
YTD Price Performance: -57.88%
Average Trading Volume: 247,601
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $218.5M
For an in-depth examination of THRD stock, go to TipRanks’ Stock Analysis page.
